UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Evolution of cortical and thalamus atrophy and disability progression in early relapsing-remitting MS during 5 years

American journal of neuroradiology : AJNR, 2013-10, Vol.34 (10), p.1931-1939

2013

Volltextzugriff (PDF)

Subcortical and Cortical Gray Matter Atrophy in a Large Sample of Patients with Clinically Isolated Syndrome and Early Relapsing-Remitting Multiple Sclerosis

American journal of neuroradiology : AJNR, 2012-09, Vol.33 (8), p.1573-1578

2012

Volltextzugriff (PDF)

Thalamic Iron Differentiates Primary-Progressive and Relapsing-Remitting Multiple Sclerosis

American journal of neuroradiology : AJNR, 2017-06, Vol.38 (6), p.1079-1086

2017

Volltextzugriff (PDF)

A Serial 10-Year Follow-Up Study of Atrophied Brain Lesion Volume and Disability Progression in Patients with Relapsing-Remitting MS

American journal of neuroradiology : AJNR, 2019-03, Vol.40 (3), p.446-452

2019

Volltextzugriff (PDF)

Identification of multiple sclerosis patients at highest risk of cognitive impairment using an integrated brain magnetic resonance imaging assessment approach

European journal of neurology, 2017-02, Vol.24 (2), p.292-301

2017

Volltextzugriff (PDF)

Demographic and clinical characteristics of treated and untreated patients with secondary progressive multiple sclerosis - analysis from three European registries

MULTIPLE SCLEROSIS JOURNAL, 2021, Vol.27 (2_SUPPL), p.204

2021

Volltextzugriff (PDF)

The impact of healthcare systems on the clinical diagnosis and disease modifying treatment usage in relapse-onset multiple sclerosis: a real-world perspective in five registries across Europe

MULTIPLE SCLEROSIS JOURNAL, 2022, Vol.28 (3_SUPPL), p.131

2022

Volltextzugriff (PDF)

Effectiveness of tixagevimab/cilgavimab (Evusheld) in antiCD20‑treated patients with multiple sclerosis and neuromyelitis optica spectrum disorder

Multiple sclerosis and related disorders, 2024-05, Vol.85, p.105523-105523, Article 105523

2024

Volltextzugriff (PDF)

Early magnetic resonance imaging predictors of clinical progression after 48 months in clinically isolated syndrome patients treated with intramuscular interferon β-1a

European journal of neurology, 2015-07, Vol.22 (7), p.1113-1123

2015

Volltextzugriff (PDF)

The incidence of metabolic syndrome in a group of obese children in Czech Republic

Atherosclerosis, 2014-08, Vol.235 (2), p.e213-e213

2014

Volltextzugriff (PDF)

Contributors to secondary progressive multiple sclerosis conversion age - a federated learning analysis across five European MS registries

MULTIPLE SCLEROSIS JOURNAL, 2021, Vol.27 (2_SUPPL), p.201

2021

Volltextzugriff (PDF)

Treatment patterns in secondary progressive multiple sclerosis a multi-country registry study from five European countries

MULTIPLE SCLEROSIS JOURNAL, 2021, Vol.27 (2_SUPPL), p.138

2021

Volltextzugriff (PDF)

Does initial high efficacy therapy in multiple sclerosis surpass escalation treatment strategy? A comparison of patients with relapsing-remitting multiple sclerosis in the Czech and Swedish national multiple sclerosis registries

Multiple sclerosis and related disorders, 2023-08, Vol.76, p.104803-104803, Article 104803

2023

Volltextzugriff (PDF)

Anti‐inflammatory disease‐modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort study

European journal of neurology, 2019-02, Vol.26 (2), p.363-370

2019

Volltextzugriff (PDF)

Risk of early relapse following the switch from injectables to oral agents for multiple sclerosis

European journal of neurology, 2016-04, Vol.23 (4), p.729-736

2016

Volltextzugriff (PDF)

Early predictors of non-response to interferon in multiple sclerosis

Acta neurologica Scandinavica, 2012-12, Vol.126 (6), p.390-397

2012

Volltextzugriff (PDF)

Longitudinal Mixed-Effect Model Analysis of the Association between Global and Tissue-Specific Brain Atrophy and Lesion Accumulation in Patients with Clinically Isolated Syndrome

American journal of neuroradiology : AJNR, 2015-08, Vol.36 (8), p.1457-1464

2015

Volltextzugriff (PDF)

Corpus Callosum Atrophy – A Simple Predictor of Multiple Sclerosis Progression: A Longitudinal 9-Year Study

European neurology, 2012-01, Vol.68 (1), p.23-27

2012

Volltextzugriff (PDF)

Multiple Sclerosis and the Accumulation of Iron in the Basal Ganglia: Quantitative Assessment of Brain Iron Using MRI T2 Relaxometry

European neurology, 2010-03, Vol.63 (3), p.136-143

2010

Volltextzugriff (PDF)

Restless legs syndrome in Czech patients with multiple sclerosis: An epidemiological and genetic study

Sleep medicine, 2012-08, Vol.13 (7), p.848-851

2012

Volltextzugriff (PDF)

Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case–control study

Journal of neurology, neurosurgery and psychiatry, 2008-04, Vol.79 (4), p.407-414

2008

Volltextzugriff (PDF)

Initiation of first disease-modifying treatment for multiple sclerosis patients in the Czech republic from 2013 to 2016: Data from the national registry ReMuS

Multiple sclerosis and related disorders, 2019-10, Vol.35, p.196-202

2019

Volltextzugriff (PDF)

Randomized study of interferon beta-1a, low-dose azathioprine, and low-dose corticosteroids in multiple sclerosis

Multiple sclerosis, 2009-08, Vol.15 (8), p.965-976

2009

Volltextzugriff (PDF)

Multiple sclerosis susceptibility loci do not alter clinical and MRI outcomes in clinically isolated syndrome

Genes and immunity, 2013-06, Vol.14 (4), p.244-248

2013

Volltextzugriff (PDF)

Interferon, azathioprine and corticosteroids in multiple sclerosis: 6-year follow-up of the ASA cohort

Clinical neurology and neurosurgery, 2012-09, Vol.114 (7), p.940-946

2012

Volltextzugriff (PDF)

1 – 25 von 236

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(198)
Mit Volltextzugriff
(150)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(2)
... seit 30 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Evolution of cortical and thalamus atrophy and disability progression in early relapsing-remitting MS during 5 years

Subcortical and Cortical Gray Matter Atrophy in a Large Sample of Patients with Clinically Isolated Syndrome and Early Relapsing-Remitting Multiple Sclerosis

Thalamic Iron Differentiates Primary-Progressive and Relapsing-Remitting Multiple Sclerosis

A Serial 10-Year Follow-Up Study of Atrophied Brain Lesion Volume and Disability Progression in Patients with Relapsing-Remitting MS

Identification of multiple sclerosis patients at highest risk of cognitive impairment using an integrated brain magnetic resonance imaging assessment approach

Demographic and clinical characteristics of treated and untreated patients with secondary progressive multiple sclerosis - analysis from three European registries

The impact of healthcare systems on the clinical diagnosis and disease modifying treatment usage in relapse-onset multiple sclerosis: a real-world perspective in five registries across Europe

Effectiveness of tixagevimab/cilgavimab (Evusheld) in antiCD20‑treated patients with multiple sclerosis and neuromyelitis optica spectrum disorder

Early magnetic resonance imaging predictors of clinical progression after 48 months in clinically isolated syndrome patients treated with intramuscular interferon β-1a

The incidence of metabolic syndrome in a group of obese children in Czech Republic

Contributors to secondary progressive multiple sclerosis conversion age - a federated learning analysis across five European MS registries

Treatment patterns in secondary progressive multiple sclerosis a multi-country registry study from five European countries

Does initial high efficacy therapy in multiple sclerosis surpass escalation treatment strategy? A comparison of patients with relapsing-remitting multiple sclerosis in the Czech and Swedish national multiple sclerosis registries

Anti‐inflammatory disease‐modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort study

Risk of early relapse following the switch from injectables to oral agents for multiple sclerosis

Early predictors of non-response to interferon in multiple sclerosis

Longitudinal Mixed-Effect Model Analysis of the Association between Global and Tissue-Specific Brain Atrophy and Lesion Accumulation in Patients with Clinically Isolated Syndrome

Corpus Callosum Atrophy – A Simple Predictor of Multiple Sclerosis Progression: A Longitudinal 9-Year Study

Multiple Sclerosis and the Accumulation of Iron in the Basal Ganglia: Quantitative Assessment of Brain Iron Using MRI T2 Relaxometry

Restless legs syndrome in Czech patients with multiple sclerosis: An epidemiological and genetic study

Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case–control study

Initiation of first disease-modifying treatment for multiple sclerosis patients in the Czech republic from 2013 to 2016: Data from the national registry ReMuS

Randomized study of interferon beta-1a, low-dose azathioprine, and low-dose corticosteroids in multiple sclerosis

Multiple sclerosis susceptibility loci do not alter clinical and MRI outcomes in clinically isolated syndrome

Interferon, azathioprine and corticosteroids in multiple sclerosis: 6-year follow-up of the ASA cohort

Suchergebnisse filtern